Biotec Pharmacon ASA (BIOTEC) - Financial and Strategic SWOT Analysis Review

  • ID: 4284943
  • SWOT Analysis
  • 25 pages
  • GlobalData
1 of 4
Summary

Biotec Pharmacon ASA (Biotec Pharmacon) is a biopharmaceutical company which develops, manufactures and markets immune modulating compounds and cold adapted enzymes. The company’s products are used in the areas of human medicine such as immunotherapy of cancer, general infection prophylaxis and imbalanced immune responses, among others. The company has developed M-Gard, an immunomodulator that enhances your body’s vital defence mechanisms against pathogens such as bacteria, virus, and fungus. Biotec Pharmacon carries out cellular or molecular level research on its proprietary beta-1,3 and 1,6-glucan products, a non-toxic modulator that improves immune resistance. The company operates through its subsidiaries in Tromso. Biotec Pharmacon is headquartered in Tromso, Norway.

Biotec Pharmacon ASA Key Recent Developments

Jan 31, 2018: Biotec Pharmacon: Fourth quarter 2017 results
Jan 16, 2018: ISO 13485 Approvals in Biotec Pharmacon
Dec 20, 2017: ArcticZymes launches two new polymerase enzymes
Oct 19, 2017: Biotec Pharmacon: Results for Q3 2017
Sep 12, 2017: Biotec Pharmacon appoints new CEO

This comprehensive SWOT profile of Biotec Pharmacon ASA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Biotec Pharmacon ASA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
Section 1 - About the Company
  • Biotec Pharmacon ASA - Key Information
  • Biotec Pharmacon ASA - Overview
  • Biotec Pharmacon ASA - Key Employees
  • Biotec Pharmacon ASA - Key Employee Biographies
  • Biotec Pharmacon ASA - Key Operational Heads
  • Biotec Pharmacon ASA - Major Products and Services
  • Biotec Pharmacon ASA - History
  • Biotec Pharmacon ASA - Company Statement
  • Biotec Pharmacon ASA - Locations And Subsidiaries
  • Biotec Pharmacon ASA - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Biotec Pharmacon ASA - Business Description
  • Biotec Pharmacon ASA - Corporate Strategy
  • Biotec Pharmacon ASA - SWOT Analysis
  • SWOT Analysis - Overview
  • Biotec Pharmacon ASA - Strengths
  • Biotec Pharmacon ASA - Weaknesses
  • Biotec Pharmacon ASA - Opportunities
  • Biotec Pharmacon ASA - Threats
  • Biotec Pharmacon ASA - Key Competitors
Section 3 - Company Financial Performance Charts
  • Biotec Pharmacon ASA - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Biotec Pharmacon ASA, Key Information
  • Biotec Pharmacon ASA, Key Ratios
  • Biotec Pharmacon ASA, Share Data
  • Biotec Pharmacon ASA, Major Products and Services
  • Biotec Pharmacon ASA, History
  • Biotec Pharmacon ASA, Key Employees
  • Biotec Pharmacon ASA, Key Employee Biographies
  • Biotec Pharmacon ASA, Key Operational Heads
  • Biotec Pharmacon ASA, Other Locations
  • Biotec Pharmacon ASA, Subsidiaries
  • Biotec Pharmacon ASA, Key Manufacturing facilities
  • Biotec Pharmacon ASA, Key Competitors
  • Biotec Pharmacon ASA, SWOT Analysis
  • Biotec Pharmacon ASA, Ratios based on current share price
  • Biotec Pharmacon ASA, Annual Ratios
  • Biotec Pharmacon ASA, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Biotec Pharmacon ASA, Performance Chart
  • Biotec Pharmacon ASA, Ratio Charts
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll